Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System

May 25, 2017 by in GYNECOLOGY Comments Off on Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System

Objective The objective of the study was to evaluate and summarize reports to the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting system, in pregnant women who received influenza…

read more

Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays

May 25, 2017 by in GYNECOLOGY Comments Off on Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays

Objective Placental growth factor and soluble Fms-like tyrosine kinase-1 may be potential diagnostic markers of preeclampsia. We compared performances of 2 immunoassays, the Triage placental growth factor assay and the…

read more

Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction

May 25, 2017 by in GYNECOLOGY Comments Off on Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction

Objective To determine maternal and perinatal outcome in women with severe preeclampsia at <26 weeks according to gestational age at the onset of expectant management and the presence of severe…

read more

Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States

May 25, 2017 by in GYNECOLOGY Comments Off on Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States

Objective The objective of the study was to estimate the potential reduction of neural tube defects (NTDs) through the use of Metafolin-fortified oral contraceptives (OCs) in the United States. Study…

read more
Get Clinical Tree app for offline access